Zobrazeno 1 - 10
of 18
pro vyhledávání: '"S. C. LAZARUS"'
Autor:
Y Wang, C Tong, Z Wang, D Mauger, K G Tantisira, E Israel, S J Szefler, V M Chinchilli, H A Boushey, S C Lazarus, R F Lemanske, R Wu
Publikováno v:
Wang, Y; Tong, C; Wang, Z; Wang, Z; Mauger, D; Tantisira, KG; et al.(2015). Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma. Pharmacogenomics Journal. doi: 10.1038/tpj.2014.83. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/44r1f8tr
The pharmacogenomics journal, vol 15, iss 5
The pharmacogenomics journal, vol 15, iss 5
© 2015 Macmillan Publishers Limited Asthma is a chronic lung disease that has a high prevalence. The therapeutic intervention of this disease can be made more effective if genetic variability in patients’ response to medications is implemented. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113b0c50a5272709d37d0e5c30328db5
https://europepmc.org/articles/PMC6156797/
https://europepmc.org/articles/PMC6156797/
Publikováno v:
Clinical Experimental Allergy. 26:710-718
Autor:
R F, Lemanske, C A, Sorkness, E A, Mauger, S C, Lazarus, H A, Boushey, J V, Fahy, J M, Drazen, V M, Chinchilli, T, Craig, J E, Fish, J G, Ford, E, Israel, M, Kraft, R J, Martin, S A, Nachman, S P, Peters, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Inhaled long-acting beta(2)-agonists improve asthma control when added to inhaled corticosteroid (ICS) therapy.To determine whether ICS therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting beta(2)-agonist
Autor:
S C, Lazarus, H A, Boushey, J V, Fahy, V M, Chinchilli, R F, Lemanske, C A, Sorkness, M, Kraft, J E, Fish, S P, Peters, T, Craig, J M, Drazen, J G, Ford, E, Israel, R J, Martin, E A, Mauger, S A, Nachman, J D, Spahn, S J, Szefler
Publikováno v:
JAMA. 285(20)
Long-acting beta(2)-agonists are prescribed for patients with persistent asthma and are sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to support their use as monotherapy in adults with persistent asthma.To examin
Autor:
E, Israel, J M, Drazen, S B, Liggett, H A, Boushey, R M, Cherniack, V M, Chinchilli, D M, Cooper, J V, Fahy, J E, Fish, J G, Ford, M, Kraft, S, Kunselman, S C, Lazarus, R F, Lemanske, R J, Martin, D E, McLean, S P, Peters, E K, Silverman, C A, Sorkness, S J, Szefler, S T, Weiss, C N, Yandava
Publikováno v:
International archives of allergy and immunology. 124(1-3)
Regular use of inhaled beta-adrenergic agonists may have adverse effects in some asthma patients. Polymorphisms of the beta(2)-adrenergic receptor (beta(2)-AR) can affect its regulation; however, results of smaller studies of the effects of such poly
Autor:
S C, Lazarus, T, Lee, J P, Kemp, S, Wenzel, L M, Dubé, R F, Ochs, P J, Carpentier, J F, Lancaster
Publikováno v:
The American journal of managed care. 4(6)
Zileuton, a leukotriene pathway inhibitor used to treat asthma, improves lung function, relieves symptoms, and is well tolerated. The purpose of this 12-month, parallel-group, open-label study was to assess the efficacy of zileuton and evaluate liver
Autor:
J E, Fish, S P, Peters, C V, Chambers, S J, McGeady, K R, Epstein, H A, Boushey, R M, Cherniack, V M, Chinchilli, J M, Drazen, J V, Fahy, S S, Hurd, E, Israel, S C, Lazarus, R F, Lemanske, R J, Martin, E A, Mauger, C, Sorkness, S J, Szefler
Publikováno v:
American journal of respiratory and critical care medicine. 156(4 Pt 1)
Colchicine demonstrates an array of anti-inflammatory properties of potential relevance to asthma. However, the efficacy of colchicine as an alternative to inhaled corticosteroid therapy for asthma is unknown. Five centers participated in a controlle
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 26(6)
Previous studies have suggested varying molecular weights for mast cell derived tumour necrosis factor alpha (TNF alpha ) and little data exist upon the factors which may regulate the control of this cytokine in these cells.To determine the molecular
Publikováno v:
The Journal of Immunology. 142:2450-2456
Submucosal glands are the major sources of airway secretions in most mammals. Mast cells are abundant in the environment of airway submucosal glands and are rich sources of secreted proteases. To investigate the hypothesis that mast cell proteases st
Publikováno v:
The Journal of Immunology. 140:2184-2192
In allergic and nonallergic lung diseases, if intraluminal mast cells adhere to airway epithelium, inflammatory mediators released from activated mast cells may reach high local concentrations and thus greatly affect airway function. To determine whe